Global (United States, European Union and China) Meningitis Vaccine Market Research Report 2019-2025

Table of Contents

1 Meningitis Vaccine Market Overview

• 1.1 Product Overview and Scope of Meningitis Vaccine
• 1.2 Meningitis Vaccine Segment by Type
  • 1.2.1 Global Meningitis Vaccine Sales Growth Rate Comparison by Type (2021-2026)
  • 1.2.2 Meningitis A+C
  • 1.2.3 Meningitis ACWY135
  • 1.2.4 Meningitis B
• 1.3 Meningitis Vaccine Segment by Application
  • 1.3.1 Meningitis Vaccine Sales Comparison by Application: 2020 VS 2026
  • 1.3.2 Medical Care
  • 1.3.3 Hospital
• 1.4 Global Meningitis Vaccine Market Size Estimates and Forecasts
  • 1.4.1 Global Meningitis Vaccine Revenue 2015-2026
  • 1.4.2 Global Meningitis Vaccine Sales 2015-2026
  • 1.4.3 Meningitis Vaccine Market Size by Region: 2020 Versus 2026

2 Global Meningitis Vaccine Market Competition by Manufacturers

• 2.1 Global Meningitis Vaccine Sales Market Share by Manufacturers (2015-2020)
• 2.2 Global Meningitis Vaccine Revenue Share by Manufacturers (2015-2020)
• 2.3 Global Meningitis Vaccine Average Price by Manufacturers (2015-2020)
• 2.4 Manufacturers Meningitis Vaccine Manufacturing Sites, Area Served, Product Type
• 2.5 Meningitis Vaccine Market Competitive Situation and Trends
  • 2.5.1 Meningitis Vaccine Market Concentration Rate
  • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
  • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
• 2.7 Primary Interviews with Key Meningitis Vaccine Players (Opinion Leaders)

3 Meningitis Vaccine Retrospective Market Scenario by Region

• 3.1 Global Meningitis Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
• 3.2 Global Meningitis Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
• 3.3 North America Meningitis Vaccine Market Facts & Figures by Country
  • 3.3.1 North America Meningitis Vaccine Sales by Country
  • 3.3.2 North America Meningitis Vaccine Sales by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Meningitis Vaccine Market Facts & Figures by Country
  • 3.4.1 Europe Meningitis Vaccine Sales by Country
  • 3.4.2 Europe Meningitis Vaccine Sales by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Meningitis Vaccine Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Meningitis Vaccine Sales by Region
  • 3.5.2 Asia Pacific Meningitis Vaccine Sales by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Meningitis Vaccine Market Facts & Figures by Country
  • 3.6.1 Latin America Meningitis Vaccine Sales by Country
  • 3.6.2 Latin America Meningitis Vaccine Sales by Country
  • 3.6.3 Mexico
  • 3.6.3 Brazil
  • 3.6.3 Argentina
• 3.7 Middle East and Africa Meningitis Vaccine Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Meningitis Vaccine Sales by Country
  • 3.7.2 Middle East and Africa Meningitis Vaccine Sales by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Meningitis Vaccine Historic Market Analysis by Type

• 4.1 Global Meningitis Vaccine Sales Market Share by Type (2015-2020)
• 4.2 Global Meningitis Vaccine Revenue Market Share by Type (2015-2020)
• 4.3 Global Meningitis Vaccine Price Market Share by Type (2015-2020)
• 4.4 Global Meningitis Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Meningitis Vaccine Historic Market Analysis by Application

• 5.1 Global Meningitis Vaccine Sales Market Share by Application (2015-2020)
• 5.2 Global Meningitis Vaccine Revenue Market Share by Application (2015-2020)
• 5.3 Global Meningitis Vaccine Price by Application (2015-2020)

6 Company Profiles and Key Figures in Meningitis Vaccine Business

• 6.1 GlaxoSmithKline
  • 6.1.1 Corporation Information
  • 6.1.2 GlaxoSmithKline Description, Business Overview and Total Revenue
  • 6.1.3 GlaxoSmithKline Meningitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
  • 6.1.4 GlaxoSmithKline Products Offered
  • 6.1.5 GlaxoSmithKline Recent Development
• 6.2 Baxter International
  • 6.2.1 Baxter International Meningitis Vaccine Production Sites and Area Served
  • 6.2.2 Baxter International Description, Business Overview and Total Revenue
  • 6.2.3 Baxter International Meningitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
  • 6.2.4 Baxter International Products Offered
  • 6.2.5 Baxter International Recent Development
• 6.3 Sanofi Pasteur
  • 6.3.1 Sanofi Pasteur Meningitis Vaccine Production Sites and Area Served
  • 6.3.2 Sanofi Pasteur Description, Business Overview and Total Revenue
  • 6.3.3 Sanofi Pasteur Meningitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
  • 6.3.4 Sanofi Pasteur Products Offered
  • 6.3.5 Sanofi Pasteur Recent Development
• 6.4 Merck
  • 6.4.1 Merck Meningitis Vaccine Production Sites and Area Served
  • 6.4.2 Merck Description, Business Overview and Total Revenue
  • 6.4.3 Merck Meningitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Merck Products Offered
  • 6.4.5 Merck Recent Development
• 6.5 Novartis
  • 6.5.1 Novartis Meningitis Vaccine Production Sites and Area Served
  • 6.5.2 Novartis Description, Business Overview and Total Revenue
  • 6.5.3 Novartis Meningitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
  • 6.5.4 Novartis Products Offered
  • 6.5.5 Novartis Recent Development
• 6.6 Pfizer
  • 6.6.1 Pfizer Meningitis Vaccine Production Sites and Area Served
  • 6.6.2 Pfizer Description, Business Overview and Total Revenue
  • 6.6.3 Pfizer Meningitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
  • 6.6.4 Pfizer Products Offered
  • 6.6.5 Pfizer Recent Development
• 6.7 Hualan
  • 6.6.1 Hualan Meningitis Vaccine Production Sites and Area Served
  • 6.6.2 Hualan Description, Business Overview and Total Revenue
  • 6.6.3 Hualan Meningitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Hualan Products Offered
  • 6.7.5 Hualan Recent Development
• 6.8 Zhejiang Tianyuan
  • 6.8.1 Zhejiang Tianyuan Meningitis Vaccine Production Sites and Area Served
  • 6.8.2 Zhejiang Tianyuan Description, Business Overview and Total Revenue
  • 6.8.3 Zhejiang Tianyuan Meningitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
  • 6.8.4 Zhejiang Tianyuan Products Offered
  • 6.8.5 Zhejiang Tianyuan Recent Development
• 6.9 Beijing Tiantan Biological
  • 6.9.1 Beijing Tiantan Biological Meningitis Vaccine Production Sites and Area Served
  • 6.9.2 Beijing Tiantan Biological Description, Business Overview and Total Revenue
  • 6.9.3 Beijing Tiantan Biological Meningitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
  • 6.9.4 Beijing Tiantan Biological Products Offered
  • 6.9.5 Beijing Tiantan Biological Recent Development

7 Meningitis Vaccine Manufacturing Cost Analysis

• 7.1 Meningitis Vaccine Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Raw Materials Price Trend
  • 7.1.3 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Meningitis Vaccine
• 7.4 Meningitis Vaccine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Meningitis Vaccine Distributors List
• 8.3 Meningitis Vaccine Customers

9 Market Dynamics

• 9.1 Market Trends
• 9.2 Opportunities and Drivers
• 9.3 Challenges
• 9.4 Porter's Five Forces Analysis

10 Global Market Forecast

• 10.1 Global Meningitis Vaccine Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Meningitis Vaccine by Type (2021-2026)
  • 10.1.2 Global Forecasted Revenue of Meningitis Vaccine by Type (2021-2026)
• 10.2 Meningitis Vaccine Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Meningitis Vaccine by Application (2021-2026)
  • 10.2.2 Global Forecasted Revenue of Meningitis Vaccine by Application (2021-2026)
• 10.3 Meningitis Vaccine Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Meningitis Vaccine by Region (2021-2026)
  • 10.3.2 Global Forecasted Revenue of Meningitis Vaccine by Region (2021-2026)
• 10.4 North America Meningitis Vaccine Estimates and Projections (2021-2026)
• 10.5 Europe Meningitis Vaccine Estimates and Projections (2021-2026)
• 10.6 Asia Pacific Meningitis Vaccine Estimates and Projections (2021-2026)
• 10.7 Latin America Meningitis Vaccine Estimates and Projections (2021-2026)
• 10.8 Middle East and Africa Meningitis Vaccine Estimates and Projections (2021-2026)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List